She's a proud graduate of Johns Hopkins University's Zanvyl Krieger School of Arts and Sciences, where she received a masters degree in communication, with an emphasis on unpacking complex topics to make them accessible and engaging.
Gastroenterology (2013) 145(5):104554
Compounded medications are not approved by the FDA and have not been reviewed for safety, effectiveness, or quality
Read review Dihexa for Autism Spectrum Disorder (ASD) The Campbell rs1858830 MET promoter C-allele autism finding (the strongest mechanistic anchor to Dihexa pharmacology), the January 2026 mGluR5 PET 16-23% lower availability, the December 2025 DAYBUE STIX (trofinetide) Rett approval, the March 2026 FDA leucovorin decision (CFD only, not autism), the 270,701 NHS open referrals breaching NICE NG142, and the ~700,000 UK autistic population
Primary Packaging Regulations Packaging is a crucial step of the compounding process to maintain the stability and quality of the preparation throughout its shelf life
Silva, D